Skip to main content

Want a detailed portfolio tracker?

Klotho Neurosciences Inc Wt Exp (KLTOW) P/E (2024 - 2026)

Klotho Neurosciences Inc Wt Exp (KLTOW) P/E from Sep 17, 2024 to Mar 11, 2026. The TTM Klotho Neurosciences Inc Wt Exp (KLTOW) P/E is -0.40. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Klotho Neurosciences Inc Wt Exp (KLTOW)

YearP/EChange
2026-0.40-10.32%
2025-0.45+397.85%
2024-0.09N/A

Comparison Klotho Neurosciences Inc Wt Exp (KLTOW) P/E with competitors

Klotho Neurosciences Inc Wt Exp (KLTOW) P/E is -0.40.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.42%
NBYStablecoin Development Corp0.00-101.07%
ENLVEnlivex Ltd0.07-118.54%
FGENFibroGen Inc0.24-159.50%
CHRSCoherus Biosciences Inc0.85-310.33%
FBIOFortress Biotech Inc0.95-335.25%
ORMPOramed Pharmaceuticals Inc1.50-472.58%
AGENAgenus Inc3.01-846.02%
INVAInnoviva Inc3.15-881.82%
VXRTVaxart Inc3.55-979.90%
CRMDCorMedix Inc3.63-999.41%
CVACCureVac N.V.4.45-1201.99%
GLPGGalapagos NV4.86-1304.42%
SRPTSarepta Therapeutics Inc4.88-1310.17%
ABEOAbeona Therapeutics Inc5.39-1435.45%
ABUSArbutus Biopharma Corp5.60-1487.03%
ZVRAZevra Therapeutics Inc5.89-1559.32%
SPROSpero Therapeutics Inc6.23-1643.90%
CGENCompugen Ltd6.31-1665.09%
RIGLRigel Pharmaceuticals6.87-1803.44%
SLXNSilexion Therapeutics Corp7.30-1908.54%
OMEROmeros Corporation9.26-2395.05%
AUPHAurinia Pharmaceuticals Inc9.58-2475.91%
PLXProtalix BioTherapeutics Inc10.89-2799.65%
ACADAcadia Pharmaceuticals Inc11.73-3007.26%
TBPHTheravance Biopharma Inc12.26-3139.53%
ADMAAdma Biologics Inc12.42-3178.20%
HRMYHarmony Biosciences Holdings Inc13.82-3525.74%
SABSSAB Biotherapeutics Inc14.14-3604.08%
NAGENiagen Bioscience Inc14.82-3773.11%
INCYIncyte Corp15.82-4022.09%
REGNRegeneron Pharmaceuticals Inc15.86-4030.54%
PBYIPuma Biotechnology Inc17.32-4392.21%
CPRXCatalyst Pharmaceuticals Inc17.44-4422.85%
EXELExelixis Inc17.54-4447.32%
TGTXTG Therapeutics Inc18.97-4801.30%
MDXGMimedx Group Inc20.55-5194.55%
XOMAXOMA Royalty Corp22.87-5770.32%
ARGXArgen X SE24.30-6123.14%
CTMXCytomX Therapeutics Inc24.82-6252.81%
XOMAOXOMA Royalty Corp25.34-6382.63%
HALOHalozyme Therapeutics Inc25.62-6451.77%
XOMAPXOMA Royalty Corp25.67-6463.27%
VRTXVertex Pharmaceuticals Inc27.99-7039.51%
RPRXRoyalty Pharma plc - Class A28.69-7211.25%
SLNOSoleno Therapeutics Inc29.02-7292.51%
ASNDAscendis Pharma A/S30.09-7557.80%
LGNDLigand Pharmaceuticals Inc - Class B37.91-9497.87%
APLSApellis Pharmaceuticals Inc39.02-9772.83%
BMRNBiomarin Pharmaceutical Inc42.21-10563.74%
KRYSKrystal Biotech Inc45.34-11340.03%
ONCBeiGene Ltd69.54-17338.14%
PHARPharming Group N.V.75.03-18697.83%
TECHBio-Techne Corp101.96-25374.11%
VCELVericel Corp109.92-27348.02%
ALNYAlnylam Pharmaceuticals Inc117.96-29341.96%
GMABGenmab140.29-34876.20%
TLXTelix Pharmaceuticals Ltd162.15-40295.51%
CORTCorcept Therapeutics Inc212.86-52864.52%